Innovation Pharmaceuticals (IPIX) Stock Plunges After Sharp Jump on Last Friday

If we look at six-month data, Innovation Pharmaceuticals (OTC: IPIX) stock had only a good trading period in February 2021. Since then, the stock had been shrinking until May 12. That day, IPIX reached the bottom of $0.18. Right now, it is going up steadily as we witnessed 25% growth last Friday.

Innovation Pharmaceuticals (IPIX) Stock Plunges After Sharp Jump on Last Friday

Biopharmaceutical company Innovation Pharmaceuticals announced its SEC Form 10-Q for the quarter ended March 31, 2021. The company had huge progress in Brilacidin’s development. It is an Innovation Pharma’s drug candidate in the new defensive-mimetics class.

Related:  Is Bionano Genomics (BNGO) a Good Biotech Stock to Buy Now?

In January, FDA (Food and Drug Administration) appointed the research of Brilacidin against COVID-19. Brilacidin has unique potential (antiviral, anti-inflammatory, antimicrobial) to treat COVID-19. There is a probability that it will be an advanced antiviral drug for the treatment of coronavirus.

Alex Krakowsky

Editor in Chief. Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life